Omega Healthcare Investors Inc (NYSE:OHI) was downgraded by Vetr from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday, April 17th. They currently have a $32.50 target price on the real estate investment trust’s stock. Vetr‘s price target would indicate a potential upside of 0.49% from the company’s current price.
A number of other equities analysts also recently weighed in on OHI. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Tuesday, February 21st. Jefferies Group LLC downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.00 target price on the stock. in a report on Tuesday, February 21st. TheStreet upgraded Omega Healthcare Investors from a “c+” rating to a “b-” rating in a report on Monday, February 6th. Finally, SunTrust Banks, Inc. downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.00 price objective on the stock. in a report on Wednesday, February 15th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Omega Healthcare Investors presently has an average rating of “Hold” and an average price target of $34.47.
Omega Healthcare Investors (NYSE:OHI) traded up 0.94% during mid-day trading on Monday, hitting $32.34. 2,188,634 shares of the stock were exchanged. The company has a 50-day moving average price of $33.25 and a 200-day moving average price of $31.67. Omega Healthcare Investors has a one year low of $28.11 and a one year high of $38.09. The company has a market cap of $6.36 billion, a P/E ratio of 15.16 and a beta of 0.51.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Wednesday, May 3rd. The real estate investment trust reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.02. Omega Healthcare Investors had a net margin of 40.67% and a return on equity of 8.86%. The company had revenue of $231.74 million during the quarter, compared to analyst estimates of $197.55 million. During the same period in the prior year, the firm earned $0.83 earnings per share. The business’s quarterly revenue was up 8.9% on a year-over-year basis. Analysts forecast that Omega Healthcare Investors will post $2.02 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, May 15th. Shareholders of record on Monday, May 1st will be given a dividend of $0.63 per share. The ex-dividend date is Thursday, April 27th. This represents a $2.52 dividend on an annualized basis and a yield of 7.79%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.62. Omega Healthcare Investors’s dividend payout ratio is presently 131.22%.
TRADEMARK VIOLATION NOTICE: This news story was published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2017/05/10/omega-healthcare-investors-inc-ohi-cut-to-sell-at-vetr-inc-updated-updated.html.
In other news, insider Steven J. Insoft sold 87,500 shares of the stock in a transaction that occurred on Tuesday, April 11th. The stock was sold at an average price of $34.00, for a total value of $2,975,000.00. Following the completion of the sale, the insider now directly owns 324,076 shares of the company’s stock, valued at $11,018,584. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Steven J. Insoft sold 12,500 shares of the firm’s stock in a transaction on Tuesday, March 14th. The stock was sold at an average price of $30.93, for a total value of $386,625.00. Following the completion of the transaction, the insider now directly owns 411,576 shares of the company’s stock, valued at $12,730,045.68. The disclosure for this sale can be found here. 4.54% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OHI. Norges Bank bought a new position in Omega Healthcare Investors during the fourth quarter valued at about $42,945,000. Allianz Asset Management AG raised its position in Omega Healthcare Investors by 4.9% in the fourth quarter. Allianz Asset Management AG now owns 79,243 shares of the real estate investment trust’s stock valued at $2,477,000 after buying an additional 3,732 shares in the last quarter. Howe & Rusling Inc. raised its position in Omega Healthcare Investors by 19.5% in the first quarter. Howe & Rusling Inc. now owns 232,679 shares of the real estate investment trust’s stock valued at $7,676,000 after buying an additional 37,905 shares in the last quarter. Bank of Montreal Can raised its position in Omega Healthcare Investors by 14.0% in the third quarter. Bank of Montreal Can now owns 223,271 shares of the real estate investment trust’s stock valued at $7,916,000 after buying an additional 27,445 shares in the last quarter. Finally, DUPONT CAPITAL MANAGEMENT Corp raised its position in Omega Healthcare Investors by 101.9% in the third quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 212,700 shares of the real estate investment trust’s stock valued at $7,540,000 after buying an additional 107,360 shares in the last quarter. Hedge funds and other institutional investors own 78.78% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
To view Vetr’s full report, visit Vetr’s official website.
What are top analysts saying about Omega Healthcare Investors Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Omega Healthcare Investors Inc and related companies.